The effects of new pharmaceutical composition containing Epigallocatechin-3-Gallate (EGCG) to inhibit methylation of the tumor supressor genes in patients with cervical intraepithelial neoplasia
- Authors: Sidorova IS1, Unanyan AL1, Drukh VM2, Muyzhnek EL3
- Affiliations:
- I.M. Sechenov First Moscow State Medical University (1st MSMU)
- Peoples’ Friendship University of Russia
- ZAO «MiraxBioPharma»
- Issue: No 3 (2014)
- Pages: 82-87
- Section: Articles
- URL: http://journals.rudn.ru/medicine/article/view/3143
- Cite item
Abstract
About the authors
I S Sidorova
I.M. Sechenov First Moscow State Medical University (1st MSMU)
Email: druhvm@gmail.com
A L Unanyan
I.M. Sechenov First Moscow State Medical University (1st MSMU)
Email: druhvm@gmail.com
V M Drukh
Peoples’ Friendship University of Russia
Email: druhvm@gmail.com
E L Muyzhnek
ZAO «MiraxBioPharma»
Email: MuyzhnekEL@ilmixgroup.ru
References
Statistics
Views
Abstract - 165
PDF (Russian) - 65
Cited-By
